Epigenetics and Inflammation in Diabetic Nephropathy

被引：33

作者：

Shao, Bao-Yi ^{[1
]}

Zhang, Shao-Fei ^{[2
]}

Li, Hai-Di ^{[2
]}

Meng, Xiao-Ming ^{[2
]}

Chen, Hai-Yong ^{[3
,4
]}

机构：

[1] Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Peoples R China

[2] Anhui Med Univ, Sch Pharm, Anhui Inst Innovat Drugs, Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei, Peoples R China

[3] Univ Hong Kong, Sch Chinese Med, Hong Kong, Peoples R China

[4] Univ Hong Kong, Dept Chinese Med, Shenzhen Hosp, Shenzhen, Peoples R China

来源：

FRONTIERS IN PHYSIOLOGY | 2021年 / 12卷

关键词：

diabetic nephropathy; epigenetics; DNA methylation; histone modifications; non-coding RNAs; inflammation; THIOREDOXIN-INTERACTING PROTEIN; GLUCOSE-INDUCED INFLAMMATION; URINARY ALBUMIN EXCRETION; RENAL FIBROSIS; GENE-EXPRESSION; KIDNEY-DISEASE; DB/DB MICE; MESENCHYMAL TRANSITION; HISTONE METHYLATION; OXIDATIVE STRESS;

D O I：

10.3389/fphys.2021.649587

中图分类号：

Q4 [生理学];

学科分类号：

071003 ;

摘要：

Diabetic nephropathy (DN) leads to high morbidity and disability. Inflammation plays a critical role in the pathogenesis of DN, which involves renal cells and immune cells, the microenvironment, as well as extrinsic factors, such as hyperglycemia, chemokines, cytokines, and growth factors. Epigenetic modifications usually regulate gene expression via DNA methylation, histone modification, and non-coding RNAs without altering the DNA sequence. During the past years, numerous studies have been published to reveal the mechanisms of epigenetic modifications that regulate inflammation in DN. This review aimed to summarize the latest evidence on the interplay of epigenetics and inflammation in DN, and highlight the potential targets for treatment and diagnosis of DN.

引用

页数：14

共 50 条

[31] Flavonoids of Coreopsis tinctoria Nutt alleviate the oxidative stress and inflammation of glomerular mesangial cells in diabetic nephropathy via RhoA/ROCK signaling
Guo, Feng
Abulati, Amila
Wang, Jing-Wei
Jiang, Jie
Zhang, Wen-Xiang
Chen, Peng-De
Yao, Lan
Mao, Xin-Min
JOURNAL OF FUNCTIONAL FOODS, 2022, 89
[32] Mapping Txnip: Key connexions in progression of diabetic nephropathy
Kumar, Anil
Mittal, Ruchika
PHARMACOLOGICAL REPORTS, 2018, 70 (03) : 614 - 622
[33] Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy
Navarro, Juan F.
Mora, Carmen
THESCIENTIFICWORLDJOURNAL, 2006, 6 : 908 - 917
[34] The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
Deng, Junyu
Liu, Ye
Liu, Yiqiu
Li, Wei
Nie, Xuqiang
JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 5273 - 5290
[35] The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress
José Butori Lopes de Faria
Kamila Cristina Silva
Jacqueline Mendonça Lopes de Faria
Hypertension Research, 2011, 34 : 413 - 422
[36] The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress
Lopes de Faria, Jose Butori
Silva, Kamila Cristina
Lopes de Faria, Jacqueline Mendonca
HYPERTENSION RESEARCH, 2011, 34 (04) : 413 - 422
[37] Inflammation and the pathogenesis of diabetic nephropathy
Wada, Jun
Makino, Hirofumi
CLINICAL SCIENCE, 2013, 124 (3-4) : 139 - 152
[38] Inflammation-activated CXCL16 pathway contributes to tubulointerstitial injury in mouse diabetic nephropathy
Hu, Ze-bo
Ma, Kun-ling
Zhang, Yang
Wang, Gui-hua
Liu, Liang
Lu, Jian
Chen, Pei-pei
Lu, Chen-chen
Liu, Bi-cheng
ACTA PHARMACOLOGICA SINICA, 2018, 39 (06) : 1022 - 1033
[39] The combination of ursolic acid and empagliflozin relieves diabetic nephropathy by reducing inflammation, oxidative stress and renal fibrosis
Wu, Xiaohan
Li, He
Wan, Zhijie
Wang, Ran
Liu, Jing
Liu, Qingfeng
Zhao, Haiyun
Wang, Zhehuan
Zhang, Huiru
Guo, Hui
Qi, Caihong
Jiao, Xiangyue
Li, Xiaotian
BIOMEDICINE & PHARMACOTHERAPY, 2021, 144
[40] Signaling pathways in diabetic nephropathy
Kawanami, Daiji
Matoba, Keiichiro
Utsunomiya, Kazunori
HISTOLOGY AND HISTOPATHOLOGY, 2016, 31 (10) : 1059 - 1067

← 1 2 3 4 5 →